Biotech Market Intelligence & Analysis
In-depth articles on the biotech landscape — market analysis, sector reports, funding trends, and company spotlights.
Japanese Biotech Market: Companies to Watch
Japan stands as a formidable and distinctive pillar in the global biotechnology landscape. It is a market defined by a deep-rooted pharmaceutical heritage, world-class scientific innovation, and a regulatory system that has evolved to champion cutting-edge therapies. While often
The Rise of European Biotech: Market Overview
For decades, the narrative of biotechnology innovation has been dominated by the United States, with its deep venture capital pools and concentrated hubs like Boston and San Francisco. However, a quiet revolution has been building across the Atlantic. European biotech is no longe
Biotech Funding in 2026: Where VCs Are Investing
As we reach the midpoint of 2026, the biotech venture funding landscape is defined by a powerful dichotomy: immense pools of capital are available, but their deployment is more disciplined and concentrated than ever before. The era of "spray and pray" investing is firmly in the r
AI in Drug Discovery: The Companies Transforming Pharma
The pharmaceutical industry is in the midst of a profound transformation, driven not by a new class of molecules, but by a new class of tools: artificial intelligence and machine learning. The traditional drug discovery process is notoriously inefficient, often described as findi
mRNA Technology: Companies Pushing the Boundaries Beyond COVID
The rapid development and deployment of mRNA-based COVID-19 vaccines was a watershed moment for medicine, validating a platform that had been in development for decades. The success of Pfizer-BioNTech's Comirnaty and Moderna's Spikevax proved that synthetic mRNA could be safely a
CRISPR Gene Editing Companies: Who's Leading the Revolution
The year 2026 is poised to be a landmark year for CRISPR-based gene editing, marking a critical transition from a revolutionary laboratory tool to a validated, commercialized therapeutic platform. The field is no longer defined by speculative potential but by tangible, regulatory
The Complete Guide to CAR-T Therapy Companies
Chimeric Antigen Receptor T-cell (CAR-T) therapy represents one of the most profound breakthroughs in modern oncology. By genetically reprogramming a patient’s own immune cells to hunt down and destroy cancer, this living drug has shifted the treatment paradigm for certain intrac
Top 50 Biotech Companies by Market Cap in 2026
As we look at the biotech landscape in 2026, the data reveals a seismic shift in global power dynamics. The traditional dominance of Western pharmaceutical giants has been decisively challenged, and in many cases, overtaken, by a wave of Asian biotech and pharmaceutical companies